cancer therapy – Page 2

Submerged Fermentation of Rhizopus sp. for l-asparaginase Production in Lymphoma Therapy

mycolabadmin

Researchers developed a new way to produce an anti-cancer enzyme called L-asparaginase using a fungus called Rhizopus, which could offer a safer alternative to current bacterial sources. They designed and tested a special bioreactor system that allows the fungus to grow as a biofilm, significantly increasing enzyme production. The system achieved enzyme activity levels much higher than previous laboratory methods, suggesting it could be scaled up for industrial pharmaceutical production.

Addressing Patient Requests to Add Dietary Supplements to Their Cancer Care—A Suggested Approach

mycolabadmin

Cancer patients often want to use dietary supplements alongside their conventional cancer treatments to manage side effects, boost immunity, and feel more in control of their health. Many patients don’t tell their doctors about supplement use because they worry about judgment or think doctors won’t understand their interests. This paper suggests doctors should have open, non-judgmental conversations with patients about supplements, evaluate their safety and effectiveness using reliable information sources, and work together with patients to make informed decisions that keep them safe while respecting their choices.

Ergostane-type steroids from mushrooms of Pleurotus genus

mycolabadmin

Oyster mushrooms and king trumpet mushrooms contain special compounds called ergostane-type steroids that have interesting chemical structures. These compounds can fight inflammation and may help with cancer. Scientists have discovered that some of these compounds have unique rearranged structures that don’t exist in other organisms. These mushroom-derived compounds show promise for developing new medicines.

Comparative transcriptome analysis reveals the genetic basis underlying the biosynthesis of polysaccharides in Hericium erinaceus

mycolabadmin

Researchers studied six different strains of lion’s mane mushrooms to understand how they produce beneficial compounds called polysaccharides. Using advanced genetic analysis, they identified thirteen key genes responsible for making these health-promoting molecules. The study found that a strain called PZH-05 produced the most polysaccharides, and its genes were more active than in other strains. This research helps explain why lion’s mane mushrooms are effective for boosting immunity, fighting cancer, and managing blood sugar.

Investigation of the In Vitro Antioxidant, Anticholinesterase, Antiurease, Antityrosinase, and Cytotoxic Properties of a Novel Compound: 4-Methoxy-2-(4-Methoxyphenyl)Benzo[d][1,3,2]Dioxaborole

mycolabadmin

Scientists created a new chemical compound containing boron that showed promise as a potential medicine. The compound was effective at neutralizing harmful molecules in cells and inhibiting enzymes related to Alzheimer’s disease. Importantly, it did not damage healthy cells or kill cancer cells, suggesting it could be safe for future medical applications in treating various diseases.

Design and Evaluation of a Inonotus obliquus–AgNP–Maltodextrin Delivery System: Antioxidant, Antimicrobial, Acetylcholinesterase Inhibitory and Cytotoxic Potential

mycolabadmin

Researchers studied Chaga mushroom from Romania and developed new ways to package and deliver its beneficial compounds using silver nanoparticles and a food-safe ingredient called maltodextrin. These new delivery systems were designed to work better in the body by improving how well the mushroom’s active ingredients dissolve and stay stable. Testing showed these enhanced formulations were very effective at fighting bacteria, protecting cells from damage, and killing cancer cells.

Comparative Multi-Omics Analysis and Antitumor Activity of Phylloporia crataegi and Phylloporia fontanesiae

mycolabadmin

Two species of medicinal fungi were studied to understand why one was better at fighting cancer cells. Researchers analyzed the chemicals, genes, and proteins in both fungi and found that Phylloporia crataegi had much higher levels of cancer-fighting compounds and activated special cellular defense pathways that harm cancer cells. This research shows that medicinal fungi could be promising sources for developing new cancer treatments.

Extraction, purification, and identification of total saponins from hazel mushroom and its application evaluation

mycolabadmin

Researchers developed an efficient method to extract beneficial compounds called saponins from hazel mushrooms using microwaves. They identified 22 different chemical compounds in these extracts and tested their effects on cancer cells and oxidative stress. The saponin extracts significantly inhibited the growth of lung cancer and bone cancer cells and demonstrated antioxidant properties, suggesting hazel mushrooms could be developed into functional foods or medicines.

Mushroom Bioactive Molecules as Anticancerous Agents: An Overview

mycolabadmin

Mushrooms contain natural compounds that show promise in fighting cancer by triggering cancer cell death and boosting immune function. Different mushroom species like oyster, shiitake, and button mushrooms contain substances such as beta-glucans and other polysaccharides that have demonstrated anticancer properties in laboratory and animal studies. While these mushroom compounds work through multiple mechanisms including preventing new blood vessel formation to tumors and stopping cancer cell division, more human clinical trials are needed to confirm their effectiveness as cancer treatments.

Research Keyword: cancer therapy